Skip to main content
Premium Trial:

Request an Annual Quote

Harvard Bioscience Buys Denville Scientific

NEW YORK (GenomeWeb News) – Life sciences instrument maker Harvard Bioscience said today that it has agreed to buy the private molecular biology company Denville Scientific for around $23 million to $24 million.

Metuchen, NJ-based Denville Scientific is focused on liquid handling items used in molecular biology research, and the company’s 2008 revenues were around $19 million.

Harvard Bioscience said that the acquisition brings with it a "well established business with an excellent organic growth history," an "extensive field sales organization," and a "significant consumables business."

The $23 million to $24 million price tag for Denville Scientific’s assets, which will be paid in three installments, is around six times the company’s estimated fiscal year 2009 profit, adjusted for certain one-time items. The total purchase price will depend on Denville’s 2009 financial results.

According to Harvard Bioscience, Denville Scientific’s revenues have grown at a rate of around 15 percent per year over the past ten years, and it expects the new business to add $.02 to $.03 to its 2009 GAAP earnings per share.

The purchase will be funded through Harvard Bioscience’s existing cash balances and its credit facility.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.